Feel­ing the pain of a bear mar­ket, Macro­Gen­ics plans to start a PhII/III by year's end — once they raise the cash

The biotech bear mar­ket has proven chal­leng­ing for com­pa­nies across the sec­tor, with sev­er­al lay­ing off staff or seek­ing merg­ers and sales. And on Tues­day …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.